Home
At a glance
Contact us
Home
Sitemap
Main Menu
About us
Debiopharm Group
Debiopharm S.A.
Debio R.P. S.A
Debioinnovation S.A.
Debiomanagement S.A.
At a glance
中文 - Chinese
Deutsch
English
Español
Français
Italiano
日本語 - Japanese
Welcome
Mission & Values
History
Our business
Business Model
Partnering
Licensing-in
Licensing-out
Partners
Pipeline
Expertise
Preclinical
Clinical
Innovative drug delivery and formulation
Manufacturing
Regulatory
Products
Eloxatin®/Elpat®
Decapeptyl® + Trelstar®/Pamorelin®
Moapar®/Salvacyl®
Responsibility
Awards
Environment
Sponsoring
Kantuta
Les Pinceaux Magiques
Sarah Marquis
Careers
Media
Press Releases
Publications
Archives
Download center
Events
Powered by Xmap!
Latest News
16 February 2012
Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932
09 November 2011
Augurix Diagnostics receives the 2011 ‘Debiopharm /Valais Award’ For its point-of-care diagnostic test for the early detection of Celiac disease
05 October 2011
The Japanese Cancer Association and Debiopharm Group™ present Doctors Arakawa and Kurokawa with the 2011 ‘JCA-Mauvernay Award’for their innovative and outstanding research in the field of cancer
About us
Our business
Responsibility
Careers
Media
Debiopharm on
Legal Notice
Credits
Sitemap
© 2012 Debiopharm Group
